RxSight's 15min chart triggers MACD and KDJ Death Crosses.

Based on the 15-minute chart of RxSight, a technical indicator analysis has revealed the occurrence of a MACD Death Cross and KDJ Death Cross on September 19, 2025, at 13:00. This suggests that the stock price has the potential to continue declining, and there is a shift in momentum towards the downside, which could result in further decreases in the stock price.

RxSight, Inc. (NASDAQ: RXST), a medical technology company specializing in light adjustable intraocular lenses (LAL) for cataract surgery, is facing a securities fraud class action lawsuit. Berger Montague PC, a renowned securities litigation law firm, has advised investors who purchased RxSight securities between May 7, 2024, and July 8, 2025, to inquire about their rights by September 22, 2025 EXPANDED CLASS PERIOD: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Inquire About a Securities Fraud Class Action by September 22, 2025^[1].

The lawsuit alleges that RxSight failed to disclose significant challenges in sales and utilization, overstated demand for its products, and was unlikely to meet its financial guidance for fiscal year 2025. On July 8, 2025, RxSight reported substantial declines in light delivery device (LDD) sales, LAL utilization, and overall revenue for Q2 2025, leading to a significant drop in stock price EXPANDED CLASS PERIOD: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Inquire About a Securities Fraud Class Action by September 22, 2025^[1].

In addition to the lawsuit, technical indicators have suggested further downward pressure on RxSight's stock price. A MACD Death Cross and KDJ Death Cross occurred on September 19, 2025, at 13:00, indicating a potential shift in momentum towards the downside RXST DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages RxSight, Inc. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action - RXST^[2].

Investors should carefully review the information provided by Berger Montague and Rosen Law Firm, both of which have encouraged investors to seek legal advice EXPANDED CLASS PERIOD: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Inquire About a Securities Fraud Class Action by September 22, 2025^[1]RXST DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages RxSight, Inc. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action - RXST^[2]. The deadline for lead plaintiff appointment is September 22, 2025. Investors can learn more about the class action by contacting Berger Montague or Rosen Law Firm.